Back
Fate Therapeutics Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Sell
24
FATE
Fate Therapeutics
Last Price:
4.08
Seasonality Move:
-2.97%
Buy
58
REGN
Regeneron Pharmaceuticals
Last Price:
903.51
Seasonality Move:
11.17%
Sell
24
Fate Therapeutics (FATE)
is a Sell
Is Fate Therapeutics a Buy, Sell or Hold?
- The current Fate Therapeutics [FATE] share price is $3.95. The Score for FATE is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- FATE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $890.59. The Score for REGN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FATE Stock Price Chart
What is Fate Therapeutics's stock price today?
-
The Fate Therapeutics share price today is $3.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing selling pressure, which indicates risk of future bearish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $890.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight selling pressure.
FATE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.77 | Sell |
| Relative Strength Index (14 RSI): | 23.81 | Sell |
| Chaikin Money Flow: | -1996012 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.53 - 6.93) | Sell |
| Bollinger Bands (100): | (3.86 - 7.16) | Sell |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -16.18 | Sell |
| Relative Strength Index (14 RSI): | 34.75 | Sell |
| Chaikin Money Flow: | -29289 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (893.6 - 949.94) | Sell |
| Bollinger Bands (100): | (886.14 - 968.2) | Sell |
FATE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.26 | Sell |
| 20-day SMA: | 5.39 | Sell |
| 50-day SMA: | 6.52 | Sell |
| 200-day SMA: | 4.07 | Sell |
| 8-day EMA: | 4.31 | Sell |
| 20-day EMA: | 5.13 | Sell |
| 50-day EMA: | 5.77 | Sell |
| 200-day EMA: | 5.73 | Sell |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 895.93 | Sell |
| 20-day SMA: | 911.39 | Sell |
| 50-day SMA: | 945.48 | Sell |
| 200-day SMA: | 865.69 | Buy |
| 8-day EMA: | 895.51 | Sell |
| 20-day EMA: | 910.56 | Sell |
| 50-day EMA: | 926.65 | Sell |
| 200-day EMA: | 876.26 | Buy |
Fate Therapeutics Earnings Growth & FATE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.15 per share, and an increase next year of $0.20 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.26 per share, an increase next quarter of $0.00 per share, an increase this year of $2.66 per share, and an increase next year of $2.13 per share.
Fate Therapeutics Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||